PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Pparg
|
ENSMUSG00000000440.13 | Pparg |
Rxrg
|
ENSMUSG00000015843.11 | Rxrg |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Rxrg | mm39_v1_chr1_+_167425953_167425978 | -0.11 | 3.5e-01 | Click! |
Pparg | mm39_v1_chr6_+_115339303_115339321 | -0.09 | 4.7e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_-_46146558 | 57.14 |
ENSMUST00000121916.8
ENSMUST00000034586.9 |
Apoc3
|
apolipoprotein C-III |
chr15_+_82336535 | 56.13 |
ENSMUST00000089129.7
ENSMUST00000229313.2 ENSMUST00000231136.2 |
Cyp2d9
|
cytochrome P450, family 2, subfamily d, polypeptide 9 |
chr11_-_77784922 | 52.33 |
ENSMUST00000017597.5
|
Pipox
|
pipecolic acid oxidase |
chr9_-_46146928 | 46.60 |
ENSMUST00000118649.8
|
Apoc3
|
apolipoprotein C-III |
chr2_+_126398048 | 44.59 |
ENSMUST00000141482.3
|
Slc27a2
|
solute carrier family 27 (fatty acid transporter), member 2 |
chr2_+_172994841 | 39.59 |
ENSMUST00000029017.6
|
Pck1
|
phosphoenolpyruvate carboxykinase 1, cytosolic |
chr13_+_91889626 | 38.79 |
ENSMUST00000022120.5
|
Acot12
|
acyl-CoA thioesterase 12 |
chr7_+_26821266 | 37.85 |
ENSMUST00000206552.2
|
Cyp2f2
|
cytochrome P450, family 2, subfamily f, polypeptide 2 |
chr3_+_82933383 | 37.28 |
ENSMUST00000029630.15
ENSMUST00000166581.4 |
Fga
|
fibrinogen alpha chain |
chr19_-_44017637 | 32.39 |
ENSMUST00000026211.10
ENSMUST00000211830.2 |
Cyp2c23
|
cytochrome P450, family 2, subfamily c, polypeptide 23 |
chr19_+_39275518 | 31.44 |
ENSMUST00000003137.15
|
Cyp2c29
|
cytochrome P450, family 2, subfamily c, polypeptide 29 |
chr3_+_94600863 | 31.29 |
ENSMUST00000090848.10
ENSMUST00000173981.8 ENSMUST00000173849.8 ENSMUST00000174223.2 |
Selenbp2
|
selenium binding protein 2 |
chrX_+_149377416 | 30.21 |
ENSMUST00000112713.3
|
Pfkfb1
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 |
chr11_-_69906171 | 29.95 |
ENSMUST00000018718.8
ENSMUST00000102574.10 |
Acadvl
|
acyl-Coenzyme A dehydrogenase, very long chain |
chr13_-_93774469 | 29.80 |
ENSMUST00000099309.6
|
Bhmt
|
betaine-homocysteine methyltransferase |
chr9_-_15212849 | 29.28 |
ENSMUST00000034414.10
|
4931406C07Rik
|
RIKEN cDNA 4931406C07 gene |
chr7_+_30193047 | 28.55 |
ENSMUST00000058280.13
ENSMUST00000133318.8 ENSMUST00000142575.8 ENSMUST00000131040.2 |
Prodh2
|
proline dehydrogenase (oxidase) 2 |
chr19_+_46120327 | 28.43 |
ENSMUST00000043739.6
ENSMUST00000237098.2 |
Elovl3
|
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 3 |
chr10_+_127637015 | 28.19 |
ENSMUST00000071646.2
|
Rdh16
|
retinol dehydrogenase 16 |
chr1_+_139429430 | 27.73 |
ENSMUST00000027615.7
|
F13b
|
coagulation factor XIII, beta subunit |
chr19_-_39729431 | 27.26 |
ENSMUST00000099472.4
|
Cyp2c68
|
cytochrome P450, family 2, subfamily c, polypeptide 68 |
chr19_-_39637489 | 26.26 |
ENSMUST00000067328.7
|
Cyp2c67
|
cytochrome P450, family 2, subfamily c, polypeptide 67 |
chr1_+_88334678 | 25.69 |
ENSMUST00000027518.12
|
Spp2
|
secreted phosphoprotein 2 |
chr2_+_24970327 | 25.13 |
ENSMUST00000044078.10
ENSMUST00000114380.9 |
Entpd8
|
ectonucleoside triphosphate diphosphohydrolase 8 |
chr11_+_69945157 | 25.09 |
ENSMUST00000108585.9
ENSMUST00000018699.13 |
Asgr1
|
asialoglycoprotein receptor 1 |
chr19_-_40175709 | 24.90 |
ENSMUST00000051846.13
|
Cyp2c70
|
cytochrome P450, family 2, subfamily c, polypeptide 70 |
chr3_+_138121245 | 24.60 |
ENSMUST00000161312.8
ENSMUST00000013458.9 |
Adh4
|
alcohol dehydrogenase 4 (class II), pi polypeptide |
chr18_+_74912268 | 24.09 |
ENSMUST00000041053.11
|
Acaa2
|
acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase) |
chr2_-_32594156 | 23.89 |
ENSMUST00000127812.3
|
Fpgs
|
folylpolyglutamyl synthetase |
chr14_+_14210932 | 23.72 |
ENSMUST00000022271.14
|
Acox2
|
acyl-Coenzyme A oxidase 2, branched chain |
chr10_+_128626772 | 23.54 |
ENSMUST00000219404.2
ENSMUST00000026411.8 |
Mmp19
|
matrix metallopeptidase 19 |
chr19_-_39875192 | 23.17 |
ENSMUST00000168838.3
|
Cyp2c69
|
cytochrome P450, family 2, subfamily c, polypeptide 69 |
chr5_-_130053120 | 22.83 |
ENSMUST00000161640.8
ENSMUST00000161884.2 ENSMUST00000161094.8 |
Asl
|
argininosuccinate lyase |
chr9_-_103105638 | 22.57 |
ENSMUST00000126359.2
|
Trf
|
transferrin |
chr17_-_35100980 | 22.08 |
ENSMUST00000152417.8
ENSMUST00000146299.8 |
C2
Gm20547
|
complement component 2 (within H-2S) predicted gene 20547 |
chr19_+_36532061 | 21.64 |
ENSMUST00000169036.9
ENSMUST00000047247.12 |
Hectd2
|
HECT domain E3 ubiquitin protein ligase 2 |
chr3_-_79535966 | 21.44 |
ENSMUST00000120992.8
|
Etfdh
|
electron transferring flavoprotein, dehydrogenase |
chr10_+_3490232 | 21.39 |
ENSMUST00000019896.5
|
Iyd
|
iodotyrosine deiodinase |
chr5_-_110434026 | 21.36 |
ENSMUST00000031472.12
|
Pxmp2
|
peroxisomal membrane protein 2 |
chr13_-_42000958 | 21.34 |
ENSMUST00000072012.10
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr15_-_82648376 | 21.28 |
ENSMUST00000055721.6
|
Cyp2d40
|
cytochrome P450, family 2, subfamily d, polypeptide 40 |
chr7_-_19415301 | 20.82 |
ENSMUST00000150569.9
ENSMUST00000127648.4 ENSMUST00000003071.10 |
Gm44805
Apoc4
|
predicted gene 44805 apolipoprotein C-IV |
chr10_+_76411474 | 20.64 |
ENSMUST00000001183.8
|
Ftcd
|
formiminotransferase cyclodeaminase |
chr7_+_140415431 | 20.53 |
ENSMUST00000209978.2
ENSMUST00000210916.2 |
Urah
|
urate (5-hydroxyiso-) hydrolase |
chr15_+_82439273 | 20.19 |
ENSMUST00000229103.2
ENSMUST00000068861.8 ENSMUST00000229904.2 |
Cyp2d12
|
cytochrome P450, family 2, subfamily d, polypeptide 12 |
chr17_-_46749370 | 20.12 |
ENSMUST00000087012.7
|
Slc22a7
|
solute carrier family 22 (organic anion transporter), member 7 |
chr3_-_153650068 | 19.92 |
ENSMUST00000150070.2
|
Acadm
|
acyl-Coenzyme A dehydrogenase, medium chain |
chr9_-_15212745 | 19.62 |
ENSMUST00000217042.2
|
4931406C07Rik
|
RIKEN cDNA 4931406C07 gene |
chr9_+_46151994 | 19.54 |
ENSMUST00000034585.7
|
Apoa4
|
apolipoprotein A-IV |
chr19_-_8382424 | 19.32 |
ENSMUST00000064507.12
ENSMUST00000120540.2 ENSMUST00000096269.11 |
Slc22a30
|
solute carrier family 22, member 30 |
chr10_-_89342493 | 19.13 |
ENSMUST00000058126.15
ENSMUST00000105296.9 |
Nr1h4
|
nuclear receptor subfamily 1, group H, member 4 |
chr2_-_25390625 | 18.96 |
ENSMUST00000040042.11
|
C8g
|
complement component 8, gamma polypeptide |
chr7_-_105249308 | 18.62 |
ENSMUST00000210531.2
ENSMUST00000033185.10 |
Hpx
|
hemopexin |
chr15_-_82678490 | 18.42 |
ENSMUST00000006094.6
|
Cyp2d26
|
cytochrome P450, family 2, subfamily d, polypeptide 26 |
chr17_-_35101069 | 18.12 |
ENSMUST00000025230.15
|
C2
|
complement component 2 (within H-2S) |
chr11_+_98337655 | 18.11 |
ENSMUST00000019456.5
|
Grb7
|
growth factor receptor bound protein 7 |
chr3_-_153650269 | 17.71 |
ENSMUST00000072697.13
|
Acadm
|
acyl-Coenzyme A dehydrogenase, medium chain |
chr3_+_89043440 | 17.71 |
ENSMUST00000047111.13
|
Pklr
|
pyruvate kinase liver and red blood cell |
chr1_+_171052623 | 17.48 |
ENSMUST00000111321.8
ENSMUST00000005824.12 ENSMUST00000111320.8 ENSMUST00000111319.2 |
Apoa2
|
apolipoprotein A-II |
chr3_+_89043879 | 17.46 |
ENSMUST00000107482.10
ENSMUST00000127058.2 |
Pklr
|
pyruvate kinase liver and red blood cell |
chr18_-_32271224 | 17.34 |
ENSMUST00000234657.2
ENSMUST00000234386.2 ENSMUST00000234651.2 |
Proc
|
protein C |
chr15_-_82291372 | 16.90 |
ENSMUST00000230198.2
ENSMUST00000230248.2 ENSMUST00000072776.5 ENSMUST00000229911.2 |
Cyp2d10
|
cytochrome P450, family 2, subfamily d, polypeptide 10 |
chr3_-_79536166 | 16.57 |
ENSMUST00000029386.14
|
Etfdh
|
electron transferring flavoprotein, dehydrogenase |
chr11_+_75358866 | 16.56 |
ENSMUST00000043598.14
ENSMUST00000108435.2 |
Tlcd2
|
TLC domain containing 2 |
chr14_-_55995912 | 16.48 |
ENSMUST00000001497.9
|
Cideb
|
cell death-inducing DNA fragmentation factor, alpha subunit-like effector B |
chr1_+_74448535 | 16.27 |
ENSMUST00000027366.13
|
Vil1
|
villin 1 |
chr4_-_61700450 | 16.26 |
ENSMUST00000107477.2
ENSMUST00000080606.9 |
Mup19
|
major urinary protein 19 |
chr16_+_4825216 | 16.16 |
ENSMUST00000185147.8
|
Smim22
|
small integral membrane protein 22 |
chr19_+_12610668 | 16.16 |
ENSMUST00000044976.12
|
Glyat
|
glycine-N-acyltransferase |
chrX_+_10118544 | 16.13 |
ENSMUST00000049910.13
|
Otc
|
ornithine transcarbamylase |
chr8_+_13076024 | 16.11 |
ENSMUST00000033820.4
|
F7
|
coagulation factor VII |
chr9_+_46180362 | 16.10 |
ENSMUST00000214202.2
ENSMUST00000215458.2 ENSMUST00000215187.2 ENSMUST00000213878.2 ENSMUST00000034584.4 |
Apoa5
|
apolipoprotein A-V |
chr15_+_9279915 | 15.82 |
ENSMUST00000022861.9
|
Ugt3a1
|
UDP glycosyltransferases 3 family, polypeptide A1 |
chr7_+_140343652 | 15.77 |
ENSMUST00000026552.9
ENSMUST00000209253.2 ENSMUST00000210235.2 |
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1 |
chr7_+_43093507 | 15.74 |
ENSMUST00000004729.5
ENSMUST00000206286.2 ENSMUST00000206196.2 ENSMUST00000206411.2 |
Etfb
|
electron transferring flavoprotein, beta polypeptide |
chr7_-_30643444 | 15.37 |
ENSMUST00000062620.9
|
Hamp
|
hepcidin antimicrobial peptide |
chr11_+_4833186 | 15.24 |
ENSMUST00000139737.2
|
Nipsnap1
|
nipsnap homolog 1 |
chr11_-_75330302 | 15.24 |
ENSMUST00000043696.9
|
Serpinf2
|
serine (or cysteine) peptidase inhibitor, clade F, member 2 |
chr11_-_75330415 | 15.11 |
ENSMUST00000128330.8
|
Serpinf2
|
serine (or cysteine) peptidase inhibitor, clade F, member 2 |
chr1_-_184543367 | 14.74 |
ENSMUST00000048462.13
ENSMUST00000110992.9 |
Mtarc1
|
mitochondrial amidoxime reducing component 1 |
chr12_+_108817043 | 14.28 |
ENSMUST00000057026.10
ENSMUST00000221080.2 |
Slc25a47
|
solute carrier family 25, member 47 |
chr2_-_32594043 | 14.28 |
ENSMUST00000143743.2
|
Fpgs
|
folylpolyglutamyl synthetase |
chr6_+_72575458 | 14.07 |
ENSMUST00000070597.13
ENSMUST00000176364.8 ENSMUST00000176168.3 |
Retsat
|
retinol saturase (all trans retinol 13,14 reductase) |
chr5_-_105387395 | 14.04 |
ENSMUST00000065588.7
|
Gbp10
|
guanylate-binding protein 10 |
chr2_-_91025441 | 13.96 |
ENSMUST00000002177.9
|
Nr1h3
|
nuclear receptor subfamily 1, group H, member 3 |
chrX_+_10118600 | 13.56 |
ENSMUST00000115528.3
|
Otc
|
ornithine transcarbamylase |
chr19_+_39980868 | 13.47 |
ENSMUST00000049178.3
|
Cyp2c37
|
cytochrome P450, family 2. subfamily c, polypeptide 37 |
chr2_-_91466739 | 13.45 |
ENSMUST00000111335.2
ENSMUST00000028681.15 |
F2
|
coagulation factor II |
chr4_+_148686985 | 13.24 |
ENSMUST00000105701.9
ENSMUST00000052060.7 |
Masp2
|
mannan-binding lectin serine peptidase 2 |
chr10_+_59239466 | 13.15 |
ENSMUST00000009790.14
|
Pla2g12b
|
phospholipase A2, group XIIB |
chr7_-_19411866 | 13.07 |
ENSMUST00000142352.9
|
Apoc2
|
apolipoprotein C-II |
chr5_+_92719336 | 13.06 |
ENSMUST00000176621.8
ENSMUST00000175974.2 ENSMUST00000131166.9 ENSMUST00000176448.8 ENSMUST00000082382.8 |
Fam47e
|
family with sequence similarity 47, member E |
chr10_-_127206300 | 12.98 |
ENSMUST00000026472.10
|
Inhbc
|
inhibin beta-C |
chr2_-_91025492 | 12.84 |
ENSMUST00000111354.2
|
Nr1h3
|
nuclear receptor subfamily 1, group H, member 3 |
chr16_+_4825170 | 12.81 |
ENSMUST00000178155.9
|
Smim22
|
small integral membrane protein 22 |
chr8_+_105573693 | 12.68 |
ENSMUST00000055052.6
|
Ces2c
|
carboxylesterase 2C |
chr11_-_78313043 | 12.64 |
ENSMUST00000001122.6
|
Slc13a2
|
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 |
chr2_-_154445578 | 12.64 |
ENSMUST00000109703.3
ENSMUST00000000896.11 |
Pxmp4
|
peroxisomal membrane protein 4 |
chr17_-_46749320 | 12.60 |
ENSMUST00000233575.2
|
Slc22a7
|
solute carrier family 22 (organic anion transporter), member 7 |
chr6_+_90310252 | 12.52 |
ENSMUST00000046128.12
ENSMUST00000164761.6 |
Uroc1
|
urocanase domain containing 1 |
chr7_+_140415170 | 12.44 |
ENSMUST00000211372.2
ENSMUST00000026554.11 ENSMUST00000185612.3 |
Urah
|
urate (5-hydroxyiso-) hydrolase |
chr13_-_42001075 | 12.43 |
ENSMUST00000179758.8
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr6_-_85846110 | 12.36 |
ENSMUST00000045008.8
|
Nat8f2
|
N-acetyltransferase 8 (GCN5-related) family member 2 |
chr9_-_103165489 | 12.35 |
ENSMUST00000035163.10
|
1300017J02Rik
|
RIKEN cDNA 1300017J02 gene |
chr2_-_91025380 | 12.32 |
ENSMUST00000111356.8
|
Nr1h3
|
nuclear receptor subfamily 1, group H, member 3 |
chr4_-_119515978 | 12.32 |
ENSMUST00000106309.9
ENSMUST00000044426.8 |
Guca2b
|
guanylate cyclase activator 2b (retina) |
chr4_-_62005498 | 12.31 |
ENSMUST00000107488.4
ENSMUST00000107472.8 ENSMUST00000084531.11 |
Mup3
|
major urinary protein 3 |
chr15_+_9335636 | 12.31 |
ENSMUST00000072403.7
|
Ugt3a2
|
UDP glycosyltransferases 3 family, polypeptide A2 |
chr15_-_82278223 | 12.28 |
ENSMUST00000170255.2
|
Cyp2d11
|
cytochrome P450, family 2, subfamily d, polypeptide 11 |
chr3_-_137837117 | 12.25 |
ENSMUST00000029805.13
|
Mttp
|
microsomal triglyceride transfer protein |
chr16_-_93726399 | 12.17 |
ENSMUST00000177648.8
ENSMUST00000142083.2 |
Cldn14
|
claudin 14 |
chr6_-_119365632 | 12.15 |
ENSMUST00000169744.8
|
Adipor2
|
adiponectin receptor 2 |
chr5_-_115257336 | 12.06 |
ENSMUST00000031524.11
|
Acads
|
acyl-Coenzyme A dehydrogenase, short chain |
chr3_+_94840352 | 12.02 |
ENSMUST00000090839.12
|
Selenbp1
|
selenium binding protein 1 |
chr10_-_128796834 | 12.01 |
ENSMUST00000026398.5
|
Mettl7b
|
methyltransferase like 7B |
chr10_+_127612243 | 11.89 |
ENSMUST00000136223.2
ENSMUST00000052652.7 |
Rdh9
|
retinol dehydrogenase 9 |
chr3_+_98187743 | 11.77 |
ENSMUST00000120541.8
ENSMUST00000090746.3 |
Hmgcs2
|
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 |
chr10_+_128104525 | 11.73 |
ENSMUST00000050901.5
|
Apof
|
apolipoprotein F |
chr17_-_31348576 | 11.70 |
ENSMUST00000024827.5
|
Tff3
|
trefoil factor 3, intestinal |
chr9_-_103165423 | 11.62 |
ENSMUST00000123530.8
|
1300017J02Rik
|
RIKEN cDNA 1300017J02 gene |
chr13_-_42001102 | 11.58 |
ENSMUST00000121404.8
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr15_-_102097387 | 11.52 |
ENSMUST00000230288.2
|
Csad
|
cysteine sulfinic acid decarboxylase |
chr9_+_108539296 | 11.49 |
ENSMUST00000035222.6
|
Slc25a20
|
solute carrier family 25 (mitochondrial carnitine/acylcarnitine translocase), member 20 |
chr7_+_140414837 | 11.40 |
ENSMUST00000106050.8
|
Urah
|
urate (5-hydroxyiso-) hydrolase |
chr19_-_8109346 | 11.39 |
ENSMUST00000065651.5
|
Slc22a28
|
solute carrier family 22, member 28 |
chr5_+_31454787 | 11.31 |
ENSMUST00000201166.4
ENSMUST00000072228.9 |
Gckr
|
glucokinase regulatory protein |
chr16_+_4825146 | 11.12 |
ENSMUST00000184439.8
|
Smim22
|
small integral membrane protein 22 |
chr8_+_105460627 | 11.07 |
ENSMUST00000034346.15
ENSMUST00000164182.3 |
Ces2a
|
carboxylesterase 2A |
chr9_-_55419442 | 10.93 |
ENSMUST00000034866.9
|
Etfa
|
electron transferring flavoprotein, alpha polypeptide |
chr10_+_127595639 | 10.76 |
ENSMUST00000128247.2
|
Rdh16f1
|
RDH16 family member 1 |
chr1_-_55127312 | 10.70 |
ENSMUST00000127861.8
ENSMUST00000144077.3 |
Hspd1
|
heat shock protein 1 (chaperonin) |
chr6_+_121320008 | 10.57 |
ENSMUST00000166457.8
|
Slc6a12
|
solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 |
chr6_-_142418801 | 10.57 |
ENSMUST00000032371.8
|
Gys2
|
glycogen synthase 2 |
chr3_+_116306719 | 10.55 |
ENSMUST00000000349.11
ENSMUST00000197201.5 |
Dbt
|
dihydrolipoamide branched chain transacylase E2 |
chr15_+_75088445 | 10.53 |
ENSMUST00000055719.8
|
Ly6g2
|
lymphocyte antigen 6 complex, locus G2 |
chr4_-_103072343 | 10.53 |
ENSMUST00000150285.8
|
Slc35d1
|
solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1 |
chr4_-_150085722 | 10.53 |
ENSMUST00000153394.2
|
H6pd
|
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
chr9_-_22046970 | 10.38 |
ENSMUST00000165735.9
|
Acp5
|
acid phosphatase 5, tartrate resistant |
chr1_-_55127183 | 10.36 |
ENSMUST00000027123.15
|
Hspd1
|
heat shock protein 1 (chaperonin) |
chr17_-_34247016 | 10.30 |
ENSMUST00000236627.2
ENSMUST00000237759.2 ENSMUST00000045467.14 ENSMUST00000114303.4 |
H2-Ke6
|
H2-K region expressed gene 6 |
chr7_-_14172434 | 10.21 |
ENSMUST00000210396.2
ENSMUST00000168252.9 |
Sult2a8
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 8 |
chr1_-_136877277 | 10.21 |
ENSMUST00000168126.7
|
Nr5a2
|
nuclear receptor subfamily 5, group A, member 2 |
chr5_+_114142842 | 10.05 |
ENSMUST00000161610.6
|
Dao
|
D-amino acid oxidase |
chr1_-_136876902 | 9.92 |
ENSMUST00000195428.2
|
Nr5a2
|
nuclear receptor subfamily 5, group A, member 2 |
chr10_-_25412010 | 9.89 |
ENSMUST00000179685.3
|
Smlr1
|
small leucine-rich protein 1 |
chr14_+_40873399 | 9.87 |
ENSMUST00000225792.2
|
Mbl1
|
mannose-binding lectin (protein A) 1 |
chr2_-_91025208 | 9.87 |
ENSMUST00000111355.8
|
Nr1h3
|
nuclear receptor subfamily 1, group H, member 3 |
chr1_+_55127110 | 9.86 |
ENSMUST00000075242.7
|
Hspe1
|
heat shock protein 1 (chaperonin 10) |
chr15_+_3300249 | 9.82 |
ENSMUST00000082424.12
ENSMUST00000159158.9 ENSMUST00000159216.10 ENSMUST00000160311.3 |
Selenop
|
selenoprotein P |
chr13_-_41981893 | 9.78 |
ENSMUST00000137905.2
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr4_-_60697274 | 9.74 |
ENSMUST00000117932.2
|
Mup12
|
major urinary protein 12 |
chr1_+_88139678 | 9.65 |
ENSMUST00000073049.7
|
Ugt1a1
|
UDP glucuronosyltransferase 1 family, polypeptide A1 |
chr13_-_41981812 | 9.61 |
ENSMUST00000223337.2
ENSMUST00000221691.2 |
Adtrp
|
androgen dependent TFPI regulating protein |
chr9_-_107546166 | 9.57 |
ENSMUST00000177567.8
|
Slc38a3
|
solute carrier family 38, member 3 |
chr14_+_122771734 | 9.53 |
ENSMUST00000154206.8
ENSMUST00000038374.13 ENSMUST00000135578.8 |
Pcca
|
propionyl-Coenzyme A carboxylase, alpha polypeptide |
chr3_-_58433313 | 9.42 |
ENSMUST00000029385.9
|
Serp1
|
stress-associated endoplasmic reticulum protein 1 |
chr10_+_87694924 | 9.38 |
ENSMUST00000095360.11
|
Igf1
|
insulin-like growth factor 1 |
chr10_+_128089965 | 9.37 |
ENSMUST00000060782.5
ENSMUST00000218722.2 |
Apon
|
apolipoprotein N |
chr5_-_38637474 | 9.35 |
ENSMUST00000143758.8
ENSMUST00000156272.8 |
Slc2a9
|
solute carrier family 2 (facilitated glucose transporter), member 9 |
chr7_+_119773070 | 9.30 |
ENSMUST00000033201.7
|
Anks4b
|
ankyrin repeat and sterile alpha motif domain containing 4B |
chr5_-_18040713 | 9.27 |
ENSMUST00000197890.5
|
Cd36
|
CD36 molecule |
chr5_+_120614587 | 9.19 |
ENSMUST00000201684.4
ENSMUST00000066540.14 |
Sds
|
serine dehydratase |
chr4_-_115504907 | 9.15 |
ENSMUST00000102707.10
|
Cyp4b1
|
cytochrome P450, family 4, subfamily b, polypeptide 1 |
chr11_+_101258368 | 9.13 |
ENSMUST00000019469.3
|
G6pc
|
glucose-6-phosphatase, catalytic |
chr6_+_82029288 | 9.12 |
ENSMUST00000149023.2
|
Eva1a
|
eva-1 homolog A (C. elegans) |
chr19_-_4548602 | 9.10 |
ENSMUST00000048482.8
|
2010003K11Rik
|
RIKEN cDNA 2010003K11 gene |
chr17_+_84990541 | 9.09 |
ENSMUST00000045714.15
ENSMUST00000171915.2 |
Abcg8
|
ATP binding cassette subfamily G member 8 |
chr2_-_69172944 | 9.03 |
ENSMUST00000102709.8
ENSMUST00000102710.10 ENSMUST00000180142.2 |
Abcb11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11 |
chr19_-_10581622 | 8.94 |
ENSMUST00000037678.7
|
Tkfc
|
triokinase, FMN cyclase |
chr15_-_102097466 | 8.80 |
ENSMUST00000023805.3
|
Csad
|
cysteine sulfinic acid decarboxylase |
chr11_+_114742619 | 8.79 |
ENSMUST00000053361.12
ENSMUST00000021071.14 ENSMUST00000136785.2 |
Gprc5c
|
G protein-coupled receptor, family C, group 5, member C |
chr16_+_31241085 | 8.79 |
ENSMUST00000089759.9
|
Bdh1
|
3-hydroxybutyrate dehydrogenase, type 1 |
chr11_+_73090270 | 8.76 |
ENSMUST00000006105.7
|
Shpk
|
sedoheptulokinase |
chr10_+_69048506 | 8.70 |
ENSMUST00000167384.8
|
Rhobtb1
|
Rho-related BTB domain containing 1 |
chr11_-_61268879 | 8.70 |
ENSMUST00000010267.10
|
Slc47a1
|
solute carrier family 47, member 1 |
chr5_-_38637624 | 8.68 |
ENSMUST00000067886.12
|
Slc2a9
|
solute carrier family 2 (facilitated glucose transporter), member 9 |
chr7_-_97066937 | 8.65 |
ENSMUST00000043077.8
|
Thrsp
|
thyroid hormone responsive |
chr15_+_76579960 | 8.61 |
ENSMUST00000229679.2
|
Gpt
|
glutamic pyruvic transaminase, soluble |
chr5_+_114284585 | 8.60 |
ENSMUST00000102582.8
|
Acacb
|
acetyl-Coenzyme A carboxylase beta |
chr5_+_31078775 | 8.59 |
ENSMUST00000201621.4
|
Khk
|
ketohexokinase |
chr5_-_18040647 | 8.56 |
ENSMUST00000082367.13
|
Cd36
|
CD36 molecule |
chr4_+_20007938 | 8.55 |
ENSMUST00000125799.8
ENSMUST00000121491.8 |
Ttpa
|
tocopherol (alpha) transfer protein |
chr9_-_86577940 | 8.55 |
ENSMUST00000034989.15
|
Me1
|
malic enzyme 1, NADP(+)-dependent, cytosolic |
chr17_-_34000804 | 8.47 |
ENSMUST00000002360.17
|
Angptl4
|
angiopoietin-like 4 |
chr17_-_84990360 | 8.47 |
ENSMUST00000066175.10
|
Abcg5
|
ATP binding cassette subfamily G member 5 |
chr13_-_63006176 | 8.39 |
ENSMUST00000021907.9
|
Fbp2
|
fructose bisphosphatase 2 |
chr11_-_89893707 | 8.32 |
ENSMUST00000020864.9
|
Pctp
|
phosphatidylcholine transfer protein |
chr5_+_114141894 | 8.31 |
ENSMUST00000086599.11
|
Dao
|
D-amino acid oxidase |
chr1_-_180023518 | 8.18 |
ENSMUST00000162769.8
ENSMUST00000161379.2 ENSMUST00000027766.13 ENSMUST00000161814.8 |
Coq8a
|
coenzyme Q8A |
chr9_+_65538352 | 8.16 |
ENSMUST00000216342.2
ENSMUST00000216382.2 |
Rbpms2
|
RNA binding protein with multiple splicing 2 |
chr16_+_4501934 | 8.15 |
ENSMUST00000060067.12
ENSMUST00000115854.4 ENSMUST00000229529.2 |
Dnaja3
|
DnaJ heat shock protein family (Hsp40) member A3 |
chr7_-_45679703 | 8.13 |
ENSMUST00000002850.8
|
Abcc6
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 6 |
chr10_+_127685785 | 8.10 |
ENSMUST00000077530.3
|
Rdh19
|
retinol dehydrogenase 19 |
chr1_+_163979384 | 8.04 |
ENSMUST00000086040.6
|
F5
|
coagulation factor V |
chr15_-_100579813 | 8.02 |
ENSMUST00000230572.2
|
Cela1
|
chymotrypsin-like elastase family, member 1 |
chr11_-_88754543 | 8.01 |
ENSMUST00000107904.3
|
Akap1
|
A kinase (PRKA) anchor protein 1 |
chr19_-_6899173 | 7.95 |
ENSMUST00000025906.12
ENSMUST00000239322.2 |
Esrra
|
estrogen related receptor, alpha |
chr9_-_103099262 | 7.88 |
ENSMUST00000170904.2
|
Trf
|
transferrin |
chr14_+_55716377 | 7.83 |
ENSMUST00000226902.2
ENSMUST00000228353.2 |
Dhrs4
|
dehydrogenase/reductase (SDR family) member 4 |
chr17_-_57535003 | 7.81 |
ENSMUST00000177046.2
ENSMUST00000024988.15 |
C3
|
complement component 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
25.9 | 103.7 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
17.5 | 52.5 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
17.4 | 52.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
14.9 | 44.6 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
12.7 | 38.2 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
12.6 | 37.8 | GO:0018931 | naphthalene metabolic process(GO:0018931) naphthalene-containing compound metabolic process(GO:0090420) |
12.3 | 49.2 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
12.2 | 49.0 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
9.9 | 39.4 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
9.5 | 28.5 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
9.4 | 37.6 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
8.4 | 33.6 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
7.0 | 21.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
6.6 | 33.2 | GO:0006548 | histidine catabolic process(GO:0006548) |
6.5 | 19.5 | GO:0044240 | negative regulation of lipoprotein oxidation(GO:0034443) multicellular organism lipid catabolic process(GO:0044240) |
6.3 | 18.8 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
6.2 | 142.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
6.1 | 24.6 | GO:0006069 | ethanol oxidation(GO:0006069) |
6.1 | 18.4 | GO:0006562 | proline catabolic process(GO:0006562) |
6.0 | 24.1 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
5.3 | 48.0 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
4.8 | 150.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
4.8 | 19.3 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) positive regulation of phospholipid catabolic process(GO:0060697) |
4.8 | 19.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) histone H3-R17 methylation(GO:0034971) bile acid signaling pathway(GO:0038183) |
4.8 | 14.3 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
4.7 | 28.0 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine salvage(GO:0071267) |
4.5 | 40.1 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
4.4 | 8.8 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
4.3 | 21.7 | GO:0034371 | chylomicron remodeling(GO:0034371) |
4.3 | 8.6 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
4.3 | 8.5 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
4.1 | 16.3 | GO:1902896 | terminal web assembly(GO:1902896) |
4.1 | 20.3 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
3.9 | 7.7 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
3.8 | 15.4 | GO:0034760 | negative regulation of iron ion transport(GO:0034757) negative regulation of iron ion transmembrane transport(GO:0034760) |
3.8 | 30.5 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
3.8 | 30.4 | GO:0002034 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
3.6 | 36.4 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
3.6 | 155.4 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
3.6 | 28.7 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
3.6 | 10.8 | GO:0046108 | uridine catabolic process(GO:0006218) uridine metabolic process(GO:0046108) |
3.6 | 17.8 | GO:0070543 | response to linoleic acid(GO:0070543) |
3.5 | 46.0 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
3.5 | 17.6 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
3.3 | 9.9 | GO:2000612 | regulation of thyroid-stimulating hormone secretion(GO:2000612) |
3.1 | 3.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
3.1 | 12.2 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
3.0 | 21.3 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
3.0 | 3.0 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
3.0 | 35.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
2.9 | 8.6 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
2.8 | 70.7 | GO:0080184 | response to phenylpropanoid(GO:0080184) |
2.7 | 8.2 | GO:2000722 | negative regulation of beta-amyloid clearance(GO:1900222) regulation of phenotypic switching(GO:1900239) negative regulation of vascular associated smooth muscle cell migration(GO:1904753) regulation of cardiac vascular smooth muscle cell differentiation(GO:2000722) positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
2.7 | 13.4 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
2.7 | 16.1 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
2.7 | 18.6 | GO:0060332 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) heme transport(GO:0015886) positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
2.6 | 10.6 | GO:0046226 | coumarin metabolic process(GO:0009804) coumarin catabolic process(GO:0046226) |
2.6 | 7.8 | GO:0048320 | axial mesoderm formation(GO:0048320) |
2.5 | 17.5 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
2.5 | 7.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
2.5 | 29.5 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
2.4 | 17.0 | GO:1904073 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
2.4 | 30.6 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
2.3 | 6.8 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
2.2 | 15.6 | GO:0015862 | uridine transport(GO:0015862) |
2.2 | 32.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
2.1 | 19.3 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
2.1 | 8.5 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
2.1 | 8.4 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
2.0 | 6.0 | GO:1903699 | tarsal gland development(GO:1903699) |
2.0 | 29.9 | GO:0015747 | urate transport(GO:0015747) |
1.9 | 5.6 | GO:0018900 | dichloromethane metabolic process(GO:0018900) |
1.9 | 5.6 | GO:1903000 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) regulation of lipid transport across blood brain barrier(GO:1903000) positive regulation of lipid transport across blood brain barrier(GO:1903002) |
1.9 | 9.3 | GO:1904970 | brush border assembly(GO:1904970) |
1.8 | 5.5 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) positive regulation of relaxation of muscle(GO:1901079) regulation of relaxation of smooth muscle(GO:1901080) positive regulation of relaxation of smooth muscle(GO:1901082) |
1.8 | 9.1 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
1.8 | 5.4 | GO:0038189 | neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) |
1.8 | 27.2 | GO:0046415 | urate metabolic process(GO:0046415) |
1.8 | 7.2 | GO:0006083 | acetate metabolic process(GO:0006083) |
1.8 | 9.0 | GO:0046618 | drug export(GO:0046618) |
1.8 | 10.7 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
1.8 | 23.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
1.8 | 10.6 | GO:0009992 | cellular water homeostasis(GO:0009992) |
1.7 | 19.2 | GO:0015879 | carnitine transport(GO:0015879) |
1.7 | 10.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.7 | 17.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
1.7 | 10.2 | GO:0015889 | cobalamin transport(GO:0015889) |
1.7 | 3.3 | GO:0006740 | NADPH regeneration(GO:0006740) |
1.6 | 8.1 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
1.6 | 12.7 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
1.6 | 17.3 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
1.6 | 9.3 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
1.5 | 4.6 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
1.5 | 44.4 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
1.5 | 8.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.4 | 5.8 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
1.4 | 5.7 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
1.4 | 7.0 | GO:1902724 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
1.4 | 6.8 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
1.3 | 21.5 | GO:0042574 | retinal metabolic process(GO:0042574) |
1.3 | 6.5 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.3 | 6.5 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
1.3 | 5.2 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
1.3 | 2.6 | GO:1903179 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
1.3 | 16.7 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
1.3 | 5.1 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
1.3 | 6.3 | GO:0042737 | drug catabolic process(GO:0042737) |
1.3 | 3.8 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
1.2 | 21.1 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
1.2 | 8.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.2 | 39.4 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
1.2 | 6.0 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
1.2 | 7.1 | GO:0061760 | antifungal innate immune response(GO:0061760) |
1.1 | 8.0 | GO:0042256 | mature ribosome assembly(GO:0042256) |
1.1 | 4.6 | GO:0060690 | epithelial cell differentiation involved in salivary gland development(GO:0060690) |
1.1 | 10.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
1.1 | 4.5 | GO:0061386 | closure of optic fissure(GO:0061386) |
1.1 | 18.9 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
1.1 | 4.4 | GO:1902081 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
1.1 | 2.2 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
1.1 | 11.0 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
1.1 | 4.4 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
1.1 | 4.4 | GO:0042335 | cuticle development(GO:0042335) |
1.1 | 3.3 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
1.1 | 14.1 | GO:0042572 | retinol metabolic process(GO:0042572) |
1.1 | 3.2 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.0 | 4.2 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
1.0 | 3.1 | GO:0021589 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
1.0 | 6.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
1.0 | 5.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
1.0 | 3.0 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
1.0 | 8.9 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
1.0 | 3.9 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
1.0 | 2.9 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
1.0 | 6.7 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
1.0 | 2.9 | GO:0015793 | glycerol transport(GO:0015793) |
0.9 | 9.4 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.9 | 6.5 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.9 | 2.8 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.9 | 5.4 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.9 | 23.5 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.9 | 6.1 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.8 | 2.5 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.8 | 18.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.8 | 4.0 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.8 | 21.6 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.8 | 11.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.8 | 8.8 | GO:0030242 | pexophagy(GO:0030242) |
0.8 | 4.7 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.8 | 3.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.7 | 7.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.7 | 3.7 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.7 | 2.2 | GO:1903093 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.7 | 2.2 | GO:0036275 | response to 5-fluorouracil(GO:0036275) |
0.7 | 2.2 | GO:0042694 | muscle cell fate specification(GO:0042694) |
0.7 | 6.3 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.7 | 9.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.7 | 6.3 | GO:0061042 | vascular wound healing(GO:0061042) |
0.7 | 2.1 | GO:0060540 | lung lobe formation(GO:0060464) diaphragm morphogenesis(GO:0060540) |
0.7 | 2.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.7 | 12.0 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.7 | 10.6 | GO:0015695 | organic cation transport(GO:0015695) |
0.7 | 3.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.7 | 11.8 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.7 | 3.9 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.7 | 3.9 | GO:1990839 | response to endothelin(GO:1990839) |
0.6 | 7.6 | GO:0006983 | ER overload response(GO:0006983) |
0.6 | 15.0 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.6 | 5.5 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.6 | 3.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
0.6 | 2.4 | GO:0015851 | nucleobase transport(GO:0015851) pyrimidine nucleobase transport(GO:0015855) |
0.6 | 6.6 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.6 | 4.2 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.6 | 3.6 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.6 | 3.5 | GO:0015676 | vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
0.6 | 5.0 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.6 | 3.3 | GO:0002159 | desmosome assembly(GO:0002159) |
0.6 | 1.7 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.6 | 2.2 | GO:0097017 | renal protein absorption(GO:0097017) |
0.5 | 4.9 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.5 | 2.6 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.5 | 9.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.5 | 3.5 | GO:0019659 | glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.5 | 1.5 | GO:1904582 | positive regulation of intracellular mRNA localization(GO:1904582) |
0.5 | 3.9 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.5 | 2.9 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.5 | 19.4 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.5 | 1.9 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.5 | 16.4 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.5 | 2.4 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.5 | 1.9 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.5 | 1.4 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.5 | 1.4 | GO:2000041 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.5 | 16.7 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.5 | 3.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.5 | 4.6 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.5 | 7.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.4 | 3.1 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.4 | 4.0 | GO:0002934 | desmosome organization(GO:0002934) |
0.4 | 1.3 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.4 | 2.2 | GO:0048539 | bone marrow development(GO:0048539) |
0.4 | 1.7 | GO:0009305 | protein biotinylation(GO:0009305) response to biotin(GO:0070781) histone biotinylation(GO:0071110) |
0.4 | 1.7 | GO:0017126 | nucleologenesis(GO:0017126) |
0.4 | 1.7 | GO:0060290 | transdifferentiation(GO:0060290) |
0.4 | 1.3 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
0.4 | 1.7 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.4 | 1.7 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.4 | 1.2 | GO:0046016 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
0.4 | 4.1 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.4 | 9.4 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.4 | 2.0 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.4 | 6.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.4 | 1.6 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.4 | 1.6 | GO:0003017 | lymph circulation(GO:0003017) |
0.4 | 1.9 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.4 | 12.3 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.4 | 0.4 | GO:0060459 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.4 | 4.2 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.4 | 2.3 | GO:0031179 | peptide modification(GO:0031179) |
0.4 | 3.0 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.4 | 16.5 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.4 | 1.5 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.4 | 1.5 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.4 | 1.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.4 | 2.8 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.4 | 6.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.3 | 1.7 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.3 | 1.0 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
0.3 | 1.0 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.3 | 2.4 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.3 | 4.1 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.3 | 2.3 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.3 | 15.4 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.3 | 14.0 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.3 | 1.0 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.3 | 1.7 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 3.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.3 | 3.2 | GO:1902741 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.3 | 1.3 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.3 | 4.4 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.3 | 6.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.3 | 14.8 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.3 | 1.5 | GO:0021898 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.3 | 33.2 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.3 | 18.1 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.3 | 2.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.3 | 7.3 | GO:0046688 | response to copper ion(GO:0046688) |
0.3 | 5.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.3 | 1.1 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.3 | 1.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.3 | 1.7 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.3 | 0.8 | GO:0071374 | response to parathyroid hormone(GO:0071107) cellular response to parathyroid hormone stimulus(GO:0071374) |
0.3 | 3.5 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.3 | 1.9 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.3 | 1.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.3 | 1.0 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.3 | 1.3 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.3 | 1.0 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
0.3 | 7.0 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.2 | 1.0 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.2 | 1.5 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.2 | 2.4 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.2 | 0.5 | GO:0003134 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) |
0.2 | 4.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 3.4 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 3.8 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 6.6 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.2 | 2.4 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 2.6 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 0.7 | GO:0097534 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.2 | 2.3 | GO:0042407 | mitochondrial protein processing(GO:0034982) cristae formation(GO:0042407) |
0.2 | 0.9 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 0.7 | GO:2000299 | negative regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000299) |
0.2 | 1.5 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.2 | 3.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 1.9 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.2 | 1.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 4.2 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 6.9 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.2 | 2.3 | GO:0097421 | liver regeneration(GO:0097421) |
0.2 | 20.3 | GO:0046849 | bone remodeling(GO:0046849) |
0.2 | 3.5 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 14.0 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.2 | 1.9 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 5.7 | GO:0002021 | response to dietary excess(GO:0002021) |
0.2 | 1.8 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.2 | 0.6 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.2 | 0.4 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.2 | 6.0 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.2 | 0.8 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.2 | 1.2 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.2 | 2.9 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.2 | 0.6 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
0.2 | 10.6 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.2 | 2.5 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.2 | 1.3 | GO:0021564 | vagus nerve development(GO:0021564) |
0.2 | 1.3 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.2 | 5.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 9.0 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.2 | 2.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 0.9 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.2 | 0.7 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 2.7 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 1.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.2 | 1.8 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 0.5 | GO:0090367 | negative regulation of mRNA modification(GO:0090367) |
0.2 | 1.1 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
0.2 | 5.5 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.2 | 3.8 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.2 | 4.8 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.2 | 4.1 | GO:0042775 | mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
0.2 | 5.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 7.1 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 5.4 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.2 | 0.8 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.2 | 4.0 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.2 | 1.6 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 8.3 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.2 | 1.9 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.2 | 2.8 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.2 | 1.5 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.2 | 0.9 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.2 | 3.6 | GO:0097006 | regulation of plasma lipoprotein particle levels(GO:0097006) |
0.2 | 1.5 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 1.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 1.9 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 2.9 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 2.0 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.4 | GO:1905077 | negative regulation of interleukin-17 secretion(GO:1905077) |
0.1 | 1.0 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 4.6 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 1.9 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 2.0 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.1 | 0.6 | GO:0046112 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) nucleobase biosynthetic process(GO:0046112) |
0.1 | 3.3 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 3.1 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 3.7 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.1 | 7.2 | GO:0010906 | regulation of glucose metabolic process(GO:0010906) |
0.1 | 0.7 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.2 | GO:0002358 | B cell homeostatic proliferation(GO:0002358) |
0.1 | 0.8 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.8 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.4 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 3.6 | GO:0034205 | beta-amyloid formation(GO:0034205) |
0.1 | 0.4 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.1 | 1.0 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 4.4 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.1 | 1.0 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 3.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 1.1 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.1 | 0.2 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
0.1 | 4.0 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.1 | 1.8 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.1 | 0.2 | GO:0036145 | dendritic cell homeostasis(GO:0036145) |
0.1 | 1.2 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.1 | 0.5 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.1 | 2.3 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 26.1 | GO:0006814 | sodium ion transport(GO:0006814) |
0.1 | 1.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.4 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
0.1 | 0.3 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.1 | 0.7 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 2.2 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 3.2 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 1.2 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 0.9 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.4 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 2.1 | GO:0035094 | response to nicotine(GO:0035094) |
0.1 | 1.4 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.1 | 1.6 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.9 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.6 | GO:0030578 | PML body organization(GO:0030578) |
0.1 | 17.9 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.1 | 0.4 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.1 | 0.7 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 1.5 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 0.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.1 | 0.8 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 2.7 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 3.3 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.1 | 0.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 3.6 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.1 | 0.5 | GO:0035878 | nail development(GO:0035878) |
0.1 | 1.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 2.9 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 2.8 | GO:0035137 | hindlimb morphogenesis(GO:0035137) |
0.1 | 0.3 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 0.7 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 1.2 | GO:0045851 | pH reduction(GO:0045851) |
0.1 | 0.9 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 2.5 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 3.3 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.1 | 1.7 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.1 | 0.3 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 1.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 2.2 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.1 | 2.3 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
0.1 | 0.5 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.1 | 1.5 | GO:0032528 | microvillus organization(GO:0032528) |
0.1 | 1.4 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.1 | 0.9 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.1 | 1.6 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 1.3 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.0 | 1.1 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.0 | 5.4 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 2.0 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.6 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.0 | 1.1 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 2.0 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.0 | 2.1 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 1.0 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.0 | 2.8 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 0.0 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.0 | 0.7 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.0 | 0.9 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.5 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 1.2 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.6 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
0.0 | 0.5 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.5 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.0 | 0.3 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.0 | 0.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.3 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.6 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.0 | 0.7 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.7 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.0 | 0.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 1.0 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 1.4 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.0 | 0.1 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
0.0 | 0.7 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.5 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.2 | 64.7 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
11.7 | 128.7 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
10.1 | 30.2 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
7.5 | 67.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
5.1 | 61.8 | GO:0042627 | chylomicron(GO:0042627) |
4.1 | 20.6 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
4.0 | 15.8 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
3.0 | 20.8 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
2.8 | 31.3 | GO:0097433 | dense body(GO:0097433) |
2.6 | 20.7 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
2.1 | 19.0 | GO:0005579 | membrane attack complex(GO:0005579) |
2.1 | 63.1 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
1.7 | 5.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.7 | 17.0 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
1.7 | 24.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
1.6 | 4.7 | GO:1902636 | kinociliary basal body(GO:1902636) |
1.4 | 20.3 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
1.3 | 33.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
1.3 | 3.9 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
1.3 | 22.8 | GO:0070852 | cell body fiber(GO:0070852) |
1.2 | 6.9 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
1.1 | 6.8 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
1.0 | 1.0 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.0 | 66.9 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
1.0 | 2.9 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.9 | 4.6 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
0.9 | 5.5 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
0.9 | 2.7 | GO:1990037 | Lewy body core(GO:1990037) |
0.9 | 12.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.8 | 4.2 | GO:0035339 | SPOTS complex(GO:0035339) |
0.8 | 16.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.8 | 116.8 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.7 | 23.0 | GO:0031528 | microvillus membrane(GO:0031528) |
0.7 | 42.4 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.7 | 2.2 | GO:0097132 | cyclin D2-CDK6 complex(GO:0097132) |
0.7 | 3.5 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.6 | 31.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.6 | 3.5 | GO:0070826 | paraferritin complex(GO:0070826) |
0.6 | 1.7 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.6 | 2.3 | GO:0005745 | m-AAA complex(GO:0005745) |
0.5 | 5.5 | GO:0030478 | actin cap(GO:0030478) |
0.5 | 8.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.5 | 1.6 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.5 | 2.7 | GO:0045160 | myosin I complex(GO:0045160) |
0.5 | 1.6 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.5 | 2.6 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.5 | 263.7 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.5 | 9.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.5 | 8.0 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.5 | 10.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.5 | 3.3 | GO:0072487 | MSL complex(GO:0072487) |
0.5 | 2.3 | GO:0005914 | spot adherens junction(GO:0005914) |
0.4 | 4.0 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
0.4 | 3.0 | GO:0070695 | FHF complex(GO:0070695) |
0.4 | 19.1 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.4 | 1.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.4 | 70.6 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.4 | 73.5 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.4 | 2.9 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 1.0 | GO:0060473 | cortical granule(GO:0060473) |
0.3 | 3.8 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.3 | 3.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 4.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 3.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.3 | 4.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.3 | 10.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.3 | 7.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.3 | 1.4 | GO:0044194 | cytolytic granule(GO:0044194) |
0.3 | 2.4 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.3 | 50.2 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.3 | 27.3 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 0.7 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.2 | 20.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 0.7 | GO:0044299 | C-fiber(GO:0044299) |
0.2 | 26.7 | GO:0005903 | brush border(GO:0005903) |
0.2 | 8.8 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.2 | 3.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 2.2 | GO:0044754 | autolysosome(GO:0044754) |
0.2 | 2.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 3.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 42.7 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 6.8 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 9.3 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 50.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 7.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 4.6 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 4.6 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.2 | 1.9 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 1.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 1.3 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 0.9 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.2 | 3.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 9.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 3.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 4.1 | GO:0034706 | sodium channel complex(GO:0034706) |
0.2 | 12.5 | GO:0014704 | intercalated disc(GO:0014704) |
0.2 | 0.8 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.1 | 1.0 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 1.9 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.6 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 4.4 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 0.7 | GO:0035841 | new growing cell tip(GO:0035841) |
0.1 | 3.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.8 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 3.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 9.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.6 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.1 | 3.2 | GO:0030120 | vesicle coat(GO:0030120) |
0.1 | 10.3 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.8 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 1.1 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 0.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 1.1 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 6.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 1.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.5 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.1 | 1.8 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 2.0 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 1.7 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 4.5 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 172.3 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 8.0 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 124.1 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 1.2 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 1.9 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.4 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.2 | GO:0034066 | RIC1-RGP1 guanyl-nucleotide exchange factor complex(GO:0034066) |
0.1 | 5.0 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 1.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 1.2 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 1.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 1.9 | GO:0002102 | podosome(GO:0002102) |
0.1 | 9.7 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 3.2 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.6 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 1.7 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.3 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.0 | 0.5 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.8 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.0 | 0.6 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 3.6 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.0 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.6 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.3 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 0.8 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 1.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 3.5 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
0.0 | 2.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.9 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.0 | 0.1 | GO:0036284 | tubulobulbar complex(GO:0036284) |
0.0 | 0.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 2.9 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.0 | 5.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 9.4 | GO:0016604 | nuclear body(GO:0016604) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
30.3 | 121.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
18.8 | 37.6 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
14.8 | 44.4 | GO:0033971 | hydroxyisourate hydrolase activity(GO:0033971) |
13.2 | 39.6 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
12.7 | 38.2 | GO:0004326 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) |
10.0 | 30.0 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
8.7 | 52.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
8.4 | 42.0 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
8.2 | 24.6 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
8.2 | 49.0 | GO:0032810 | sterol response element binding(GO:0032810) |
7.8 | 38.8 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
7.4 | 29.7 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
7.0 | 21.1 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
6.9 | 41.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
6.4 | 242.3 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
6.0 | 17.9 | GO:0045030 | UTP-activated nucleotide receptor activity(GO:0045030) |
5.7 | 22.8 | GO:0016842 | amidine-lyase activity(GO:0016842) |
5.4 | 27.2 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
5.4 | 16.2 | GO:0047936 | glucose 1-dehydrogenase [NAD(P)] activity(GO:0047936) |
5.1 | 20.4 | GO:0018455 | alcohol dehydrogenase [NAD(P)+] activity(GO:0018455) |
4.8 | 19.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
4.7 | 32.6 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
4.6 | 46.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
4.6 | 18.4 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
4.4 | 13.3 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
4.4 | 30.5 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
4.3 | 21.7 | GO:0035478 | chylomicron binding(GO:0035478) |
4.0 | 16.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
3.9 | 15.7 | GO:0005118 | sevenless binding(GO:0005118) |
3.9 | 11.8 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
3.8 | 19.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
3.7 | 29.8 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
3.7 | 11.0 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
3.6 | 17.8 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
3.5 | 10.6 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
3.5 | 21.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
3.5 | 17.3 | GO:0070012 | oligopeptidase activity(GO:0070012) |
3.2 | 15.9 | GO:0004021 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
3.2 | 9.5 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
3.1 | 18.6 | GO:0015232 | heme transporter activity(GO:0015232) |
3.1 | 58.5 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
3.0 | 35.8 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
3.0 | 53.7 | GO:0008430 | selenium binding(GO:0008430) |
3.0 | 8.9 | GO:0034012 | glycerone kinase activity(GO:0004371) FAD-AMP lyase (cyclizing) activity(GO:0034012) triokinase activity(GO:0050354) |
2.9 | 8.8 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
2.9 | 20.3 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
2.9 | 8.6 | GO:0004454 | ketohexokinase activity(GO:0004454) |
2.9 | 8.6 | GO:0008431 | vitamin E binding(GO:0008431) |
2.8 | 8.5 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
2.8 | 48.0 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
2.6 | 10.6 | GO:0004063 | aryldialkylphosphatase activity(GO:0004063) |
2.6 | 10.3 | GO:0070404 | NADH binding(GO:0070404) |
2.5 | 29.5 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
2.4 | 12.1 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
2.4 | 7.2 | GO:0019807 | aspartoacylase activity(GO:0019807) |
2.4 | 9.6 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) |
2.3 | 48.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
2.3 | 9.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
2.2 | 13.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
2.2 | 44.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
2.2 | 6.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
2.2 | 6.6 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
2.1 | 61.6 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
2.1 | 6.3 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
2.1 | 12.3 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
2.0 | 16.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
2.0 | 24.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
1.9 | 11.5 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
1.9 | 5.7 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
1.9 | 5.6 | GO:0016824 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
1.8 | 10.8 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
1.8 | 10.7 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
1.7 | 8.6 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
1.7 | 6.8 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
1.6 | 6.5 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
1.6 | 4.7 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
1.5 | 6.0 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
1.4 | 5.7 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
1.4 | 5.6 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
1.4 | 9.7 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
1.4 | 31.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
1.3 | 12.1 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
1.3 | 5.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.3 | 36.1 | GO:0001848 | complement binding(GO:0001848) |
1.3 | 5.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
1.2 | 33.6 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
1.2 | 7.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
1.2 | 7.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
1.2 | 4.8 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
1.2 | 15.5 | GO:0016151 | nickel cation binding(GO:0016151) |
1.1 | 4.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
1.1 | 4.6 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
1.1 | 10.2 | GO:0031419 | cobalamin binding(GO:0031419) |
1.1 | 27.1 | GO:0071949 | FAD binding(GO:0071949) |
1.1 | 25.1 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
1.1 | 6.5 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
1.1 | 4.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.1 | 9.5 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
1.0 | 2.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
1.0 | 1.0 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
1.0 | 3.0 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
1.0 | 6.0 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
1.0 | 17.8 | GO:0034185 | apolipoprotein binding(GO:0034185) |
1.0 | 11.7 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.0 | 7.7 | GO:0005124 | scavenger receptor binding(GO:0005124) |
1.0 | 2.9 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
1.0 | 20.9 | GO:0044548 | S100 protein binding(GO:0044548) |
0.9 | 3.8 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.9 | 8.4 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.9 | 9.3 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.9 | 6.5 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.9 | 37.8 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.9 | 6.4 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.8 | 6.7 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.8 | 8.4 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.8 | 2.4 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.8 | 4.0 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.8 | 20.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.8 | 7.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.8 | 3.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.7 | 4.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.7 | 5.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.7 | 5.8 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.7 | 5.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.7 | 2.8 | GO:0033797 | selenate reductase activity(GO:0033797) |
0.7 | 7.8 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.7 | 3.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.7 | 6.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.7 | 8.7 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.7 | 3.9 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.6 | 5.2 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) ether hydrolase activity(GO:0016803) |
0.6 | 4.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.6 | 5.6 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.6 | 5.0 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.6 | 2.5 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.6 | 8.0 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.6 | 1.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.6 | 1.8 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.6 | 10.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.6 | 11.1 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.6 | 6.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.6 | 4.0 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.6 | 4.0 | GO:0030614 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.6 | 14.7 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.6 | 16.7 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.6 | 32.1 | GO:0009055 | electron carrier activity(GO:0009055) |
0.6 | 2.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.5 | 2.2 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.5 | 4.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.5 | 2.0 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.5 | 21.5 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.5 | 18.9 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.5 | 2.4 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.5 | 1.4 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
0.5 | 3.8 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.5 | 20.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.5 | 1.9 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
0.5 | 3.2 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.4 | 1.3 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.4 | 3.1 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.4 | 4.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.4 | 6.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.4 | 2.2 | GO:0002046 | opsin binding(GO:0002046) |
0.4 | 1.7 | GO:0004080 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
0.4 | 1.6 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.4 | 7.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.4 | 5.3 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.4 | 1.2 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.4 | 1.6 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
0.4 | 5.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.4 | 9.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.4 | 2.7 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.4 | 1.1 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.4 | 3.4 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.4 | 13.5 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.4 | 2.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.4 | 84.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.4 | 3.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.4 | 2.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.4 | 7.3 | GO:0030957 | Tat protein binding(GO:0030957) |
0.4 | 26.2 | GO:0005507 | copper ion binding(GO:0005507) |
0.4 | 4.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 7.8 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.3 | 1.7 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.3 | 1.0 | GO:0070002 | glutamic-type peptidase activity(GO:0070002) |
0.3 | 4.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 1.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.3 | 37.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.3 | 1.0 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.3 | 3.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 1.9 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.3 | 0.9 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.3 | 18.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 0.9 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.3 | 4.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 4.7 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.3 | 0.9 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
0.3 | 14.7 | GO:0043531 | ADP binding(GO:0043531) |
0.3 | 2.6 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.3 | 0.9 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) diacylglycerol O-acyltransferase activity(GO:0004144) |
0.3 | 1.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 3.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.3 | 3.0 | GO:0010181 | FMN binding(GO:0010181) |
0.3 | 4.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 15.4 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.3 | 1.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.3 | 0.8 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
0.3 | 5.2 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.3 | 3.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.3 | 1.8 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 2.9 | GO:0071813 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.2 | 1.0 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.2 | 2.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.2 | 3.9 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.2 | 0.9 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 1.8 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 0.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 34.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 1.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 2.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 5.7 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.2 | 0.6 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.2 | 8.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 2.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.2 | 13.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 3.8 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 5.1 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.2 | 4.4 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.2 | 0.6 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 2.3 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.2 | 10.0 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.2 | 5.8 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.2 | 0.7 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.2 | 1.7 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 2.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 1.5 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.2 | 19.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 2.0 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.2 | 1.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 1.2 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.2 | 0.9 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.2 | 5.0 | GO:0020037 | heme binding(GO:0020037) |
0.1 | 0.6 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.1 | 0.4 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
0.1 | 6.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 16.3 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 2.8 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 4.8 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 3.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 3.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 17.8 | GO:0005506 | iron ion binding(GO:0005506) |
0.1 | 2.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 1.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 0.4 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 6.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 1.5 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 1.6 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.5 | GO:0019809 | spermidine binding(GO:0019809) |
0.1 | 2.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 3.7 | GO:0046961 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 1.8 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 3.7 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 2.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 1.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 1.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 2.9 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 10.7 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 3.7 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.5 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 2.5 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 3.8 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 0.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.4 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 11.9 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 1.6 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.6 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 7.9 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.1 | 3.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 1.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 0.9 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 1.0 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.1 | 11.0 | GO:0015293 | symporter activity(GO:0015293) |
0.1 | 0.5 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.1 | 4.9 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 0.8 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 10.8 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 1.8 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.1 | 1.1 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.1 | 1.8 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 1.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 3.8 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 3.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 2.4 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 2.5 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 1.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.6 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 1.1 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 1.7 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 0.2 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 0.8 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 2.7 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 12.4 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.1 | 1.9 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 2.6 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 1.5 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.5 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 0.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.0 | 1.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.6 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 14.0 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.6 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 1.5 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 10.8 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.0 | 0.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.9 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.0 | 0.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.6 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 183.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.2 | 67.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.6 | 29.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.5 | 19.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.5 | 4.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.5 | 6.9 | ST STAT3 PATHWAY | STAT3 Pathway |
0.5 | 15.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 11.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.4 | 17.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.4 | 11.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.4 | 104.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 4.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 5.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 5.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 4.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 17.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 13.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 14.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 5.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 25.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 5.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 4.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 8.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 1.9 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 8.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 3.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 2.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 8.3 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 2.7 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 2.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 1.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 1.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 3.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 1.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 7.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 2.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 1.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 1.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 1.4 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 2.9 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 1.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 1.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 2.0 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 2.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 1.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 2.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.6 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.5 | 188.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
6.1 | 103.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
5.3 | 15.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
5.2 | 89.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
4.6 | 74.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
3.4 | 79.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
2.5 | 32.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
2.5 | 39.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
2.2 | 24.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.8 | 20.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
1.8 | 16.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
1.7 | 57.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
1.4 | 12.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.4 | 23.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
1.3 | 18.5 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
1.3 | 64.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
1.0 | 21.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
1.0 | 32.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
1.0 | 16.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.0 | 73.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.9 | 19.4 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.9 | 22.0 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.9 | 19.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.9 | 72.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.8 | 15.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.8 | 84.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.8 | 164.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.7 | 22.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.7 | 9.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.6 | 32.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.6 | 13.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.6 | 10.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.5 | 9.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.5 | 9.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.5 | 5.8 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.5 | 4.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.5 | 17.8 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.5 | 8.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.5 | 29.3 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.5 | 18.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.4 | 3.5 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.4 | 14.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.4 | 22.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.4 | 6.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.4 | 1.6 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.4 | 8.1 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.4 | 4.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.4 | 10.6 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.4 | 3.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.4 | 24.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.4 | 14.5 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.3 | 4.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 1.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.3 | 4.9 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.3 | 6.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 8.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.3 | 3.5 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.3 | 3.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 4.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.3 | 9.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.3 | 3.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 3.7 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.2 | 5.9 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.2 | 0.7 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.2 | 3.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 2.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 4.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.2 | 1.8 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 2.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 14.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 4.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 5.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 14.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 5.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 5.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 1.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 1.6 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.1 | 1.0 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 2.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 2.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 2.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 2.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.9 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 1.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 2.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 3.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 2.6 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.1 | 1.2 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 0.5 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 2.0 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 1.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 1.0 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 1.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 1.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.4 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 2.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.9 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 1.5 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.0 | 0.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 1.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 1.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 1.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |